|Mr. Frédéric Amar||Chief Exec. Officer and Exec. Director||533k||N/A||53|
|Henk L. Hakvoort||Fin. Director||N/A||N/A||N/A|
|Aurelie Martin||Head of Marketing||N/A||N/A||N/A|
|Karol Kindy||HR Mang.||N/A||N/A||N/A|
|Dr. Ramesh Bhonde||Chief Technical Officer of Indian region||N/A||N/A||N/A|
Esperite N.V., together with its subsidiaries, operates as a family stem cell bank in Spain, Italy, and internationally. It operates through four segments: Stem Cell, The Cell Factory, Genoma, and Other. The company collects, processes, and stores human adult stem cells from the umbilical cord blood and the umbilical cord tissue. It also provides proteomics and genomics predictive medicine; implements its own proprietary new technology for clinical grade production of autologous mesenchymal and stromal stem cells; and offers cytogenetic analysis through next generation sequencing platforms. The companys products portfolio includes Tranquility, a non-invasive prenatal test that detects fetal chromosomal abnormalities utilizing a single blood draw from the mother; and Verity, a test for the inborn errors of metabolism of newborns and children utilizing the gas chromatography/mass spectrometry technology. The company was formerly known as Cryo-Save Group N.V. and changed its name to Esperite N.V. in July 2014. Esperite N.V. was founded in 2000 and is based in Zutphen, the Netherlands.
Esperite N.V.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.